EPO and anemia: Furthermore, in recent animal (14–16) and human (17–19) studies, anaemia itself has been proposed to increase the risk of NEC, a concept supported by studies demonstrating that the use of erythropoietin (EPO) to treat anaemia may also decrease NEC (14, 20).